This article from Biotech Metro highlights how Reselute is developing innovative medical device technology designed to address complex orthopedic infections.
The feature explores the company’s advanced implant platform, which combines load-bearing biomaterials with localized antibiotic delivery to treat infections directly at the source while supporting bone healing. The technology aims to improve outcomes for patients with post-surgical and trauma-related infections while reducing complications associated with traditional orthopedic implants.
